Streetbeat News

Revenues

BA

EADSY

Airbus SE reported its 9-month revenues at €44.5 billion and Q3 EBIT at €2.7 billion, maintaining its guidance. The free cash flow before customer financing was €-0.8 billion.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 4:49 pm

HAIL

PSNY

TSLA

Polestar Automotive Holding (NASDAQ:PSNY) shares are trading lower as the company expands access to Tesla Superchargers in North America and updates its charging infrastructure. Despite these developments, PSNY stock has dropped over 30% in the past month, with a recent 5.95% decline. Polestar's Q3 vehicle deliveries decreased by 15% year-over-year.

Portfolio Pulse from Nabaparna Bhattacharya

October 30, 2024 | 4:46 pm

MULN

Mullen Automotive's Bollinger Motors has delivered its first West Coast EV trucks, marking a significant milestone. The delivery of three Bollinger B4 Chassis Cabs to TEC Equipment dealerships is valued at nearly $500,000. The trucks qualify for federal and state incentives, potentially saving over $100,000 per vehicle. Mullen's shares rose by 3.96% following the news.

Portfolio Pulse from Lekha Gupta

October 30, 2024 | 4:30 pm

FVRR

Fiverr International Ltd (NYSE:FVRR) reported strong Q3 fiscal 2024 results, with sales and EPS beating analyst estimates. Despite a decrease in active buyers, spend per buyer increased, and the company showed progress in profitability. Fiverr's stock rose significantly following the earnings report.

Portfolio Pulse from Anusuya Lahiri

October 30, 2024 | 4:21 pm

PRVA

Privia Health Group's shares are rising following the announcement that its accountable care organizations saved $176.6 million through the Medicare shared savings program in 2023.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 4:20 pm

ALSN

Allison Transmission shares rose following strong Q3 results and an increase in FY24 revenue guidance. Baird and Oppenheimer also raised their price targets for the stock.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 4:07 pm

BPMC

Blueprint Medicines shares rose after the company reported strong Q3 results and increased its FY24 revenue guidance. Needham reiterated a Buy rating.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 4:03 pm

ITCI

Intra-Cellular Therapies shares rose following a strong Q3 revenue report and an increase in FY24 sales guidance. Needham reiterated a Buy rating on the stock.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 4:00 pm

VST

Vistra (NYSE:VST) has significantly outperformed the market over the past 5 years, with an annualized return of 36.84%. A $100 investment in Vistra 5 years ago would now be worth $462.10. The article highlights the impact of compounded returns on investment growth.

Portfolio Pulse from Benzinga Insights

October 30, 2024 | 4:00 pm

FCNCA

First Citizens BancShares (NASDAQ:FCNCA) has significantly outperformed the market over the past decade, with an average annual return of 22.95%. A $100 investment in FCNCA 10 years ago would now be worth $784.81, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

October 30, 2024 | 4:00 pm